These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10065756)

  • 1. Syncope following intramuscular injection of hydroxocobalamin in a paraplegic patient: indication for oral administration of cyanocobalamin in spinal cord injury patients.
    Vaidyanathan S; Soni BM; Oo T; Watt JW; Sett P; Singh G
    Spinal Cord; 1999 Feb; 37(2):147-9. PubMed ID: 10065756
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of vitamin B12 deficiency. Evaluation of therapy with cyanocobalamin, hydroxocabalamin, and depot cobalamin Betolvex.
    Bastrup-Madsen P
    Scand J Gastroenterol Suppl; 1974; 29():89-95. PubMed ID: 4530460
    [No Abstract]   [Full Text] [Related]  

  • 3. Sublingual cobalamin for pernicious anaemia.
    Freeman AG
    Lancet; 1999 Dec; 354(9195):2080; author reply 2081. PubMed ID: 10636395
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral or parenteral therapy for vitamin B12 deficiency.
    Snowden JA; Chan-Lam D; Thomas SE; Ng JP
    Lancet; 1999 Jan; 353(9150):411. PubMed ID: 9950474
    [No Abstract]   [Full Text] [Related]  

  • 5. Patient variation in pernicious anaemia, as shown in a clinical trial of cyanocobalamin, hydroxocobalamin and cyanocobalamin--zinc tannate.
    Tudhope GR; Swan HT; Spray GH
    Br J Haematol; 1967 Mar; 13(2):216-28. PubMed ID: 6019807
    [No Abstract]   [Full Text] [Related]  

  • 6. Type I immediate hypersensitivity reaction to cyanocobalamin but not hydroxycobalamin.
    Moloney FJ; Hughes R; O'Shea D; Kirby B
    Clin Exp Dermatol; 2008 Jul; 33(4):412-4. PubMed ID: 18498413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of vertebragenous pain and sensitivity disorders using high doses of hydroxocobalamin].
    Hieber H
    Med Monatsschr; 1974 Dec; 28(12):545-8. PubMed ID: 4281049
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of hydroxocobalamin and cyanocobalamin in the treatment of pernicious anaemia.
    Chalmers JN; Shinton NK
    Lancet; 1965 Dec; 2(7426):1305-8. PubMed ID: 4165301
    [No Abstract]   [Full Text] [Related]  

  • 9. Maintenance therapy of pernicious anaemia. Comparison of cyanocobalamin, hydroxocobalamin and a cyanocobalamin-zinc-tannate complex.
    Killander A; Werner I
    Acta Haematol; 1968; 40(6):305-14. PubMed ID: 4978697
    [No Abstract]   [Full Text] [Related]  

  • 10. Sensitivity to cyanocobalamin and hydroxocobalamin.
    James J; Warin RP
    Br Med J; 1971 May; 2(5756):262. PubMed ID: 5572387
    [No Abstract]   [Full Text] [Related]  

  • 11. IGE-mediated reaction to hydroxocobalamin injection in patient with pernicious anaemia.
    de Blay F; Sager MF; Hirth C; Alt M; Chamouard P; Baumann R; Pauli G
    Lancet; 1992 Jun; 339(8808):1535-6. PubMed ID: 1351201
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxocobalamin as a cyanide antidote.
    DesLauriers CA; Burda AM; Wahl M
    Am J Ther; 2006; 13(2):161-5. PubMed ID: 16645433
    [No Abstract]   [Full Text] [Related]  

  • 13. STUDIES ON VITAMIN B12 RETENTION. COMPARISON OF RETENTION FOLLOWING INTRAMUSCULAR INJECTION OF CYANOCOBALAMIN AND HYDROXOCOBALAMIN.
    HERTZ H; KRISTENSEN HP; HOFF-JORGENSEN E
    Scand J Haematol; 1964; 1():5-15. PubMed ID: 14175719
    [No Abstract]   [Full Text] [Related]  

  • 14. Veinous Staining and Chromaturia associated with Hydroxocobalamin Infusion.
    Goodman D; Davidson C
    BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38649239
    [No Abstract]   [Full Text] [Related]  

  • 15. Relation of blood cyanide to plasma cyanocobalamin concentration after a fixed dose of hydroxocobalamin in cyanide poisoning.
    Houeto P; Hoffman JR; Imbert M; Levillain P; Baud FJ
    Lancet; 1995 Sep; 346(8975):605-8. PubMed ID: 7651005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case 30-2004: a woman with paresthesias.
    Davies SV
    N Engl J Med; 2005 Jan; 352(4):419-20; author reply 419-20. PubMed ID: 15673813
    [No Abstract]   [Full Text] [Related]  

  • 17. Early biomarker response and patient preferences to oral and intramuscular vitamin B12 substitution in primary care: a randomised parallel-group trial.
    Metaxas C; Mathis D; Jeger C; Hersberger KE; Arnet I; Walter P
    Swiss Med Wkly; 2017; 147():w14421. PubMed ID: 28421567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Action of massive doses of cyanocobalamin in otorhinolaryngologic neoplasms].
    Natali R
    Ann Otolaryngol Chir Cervicofac; 1969; 86(7):501-5. PubMed ID: 4187129
    [No Abstract]   [Full Text] [Related]  

  • 19. Anaphylactic reaction after injection of vitamin B12.
    Hovding G
    Br Med J; 1968 Jul; 3(5610):102. PubMed ID: 5662949
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical and clinical response to hydroxocobalamin versus cyanocobalamin treatment in patients with methylmalonic acidemia and homocystinuria (cblC).
    Andersson HC; Shapira E
    J Pediatr; 1998 Jan; 132(1):121-4. PubMed ID: 9470012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.